Press release
Driving Donepezil Market Growth in 2025: The Role of Rising Alzheimer's Cases Propel Growth Of The Market
Donepezil Market
Donepezil Market Size Growth Forecast: What to Expect by 2025?
The market size for donepezil has seen a consistent growth in the recent past and is projected to grow from $1 billion in 2024 to $1.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.1%. Factors contributing to growth during the historic period include an increase in the incidence of Alzheimer's disease, a surge in the aged population, an upswing in public sector spending and initiatives, heightened understanding of neurodegenerative disorders, and a leap in the demand for high-quality nucleic acid samples.
How Will the Donepezil Market Size Evolve and Grow by 2029?
In the coming years, the market size for donepezil is slated to experience consistent expansion, with predictions suggesting it'll reach "$1.24 billion in 2029", reflecting a compound annual growth rate (CAGR) of 4.5%. The forecast period growth is driven by factors such as increasing healthcare spending, a heightened emphasis on early Alzheimer's detection, surging demand for combined therapies, and investment boosts in healthcare infrastructure, as well as a rising cognizance of neurodegenerative diseases. Key trends projected for this forecast period involve improvements in medication formulations and delivery techniques, technological progress, the introduction of innovative dosage types and formulations, the authorization of donepezil's generic versions, and the establishment of advanced research facilities.
View the full report here:
https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report
What Drivers Are Propelling the Growth of Donepezil Market Forward?
The upward trend in Alzheimer's disease cases is believed to be a key driver for the expansion of the donepezil market. Alzheimer's disease, marked by progressive neurologic disorder leading to degeneration and death of brain cells, manifests in memory loss, cognitive impairment, and behavioral alterations. Factors such as aging, population growth, and lifestyle, coupled with increasing chronic diseases, genetic components, and environmental exposures contribute to the surge in Alzheimer's disease cases. Donepezil proves beneficial in symptom management for Alzheimer's disease through boosting cognitive abilities and daily living skills by acting on brain acetylcholine levels. For example, data from a May 2024 report by the Alzheimer's Association, a nonprofit U.S. organization concerned with Alzheimer's care, support, and research, showed that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. As a result, the escalating prevalence of Alzheimer's disease is fueling the growth of the donepezil market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp
What Are the Key Trends Driving Donepezil Market Growth?
Prominent players in the donepezil market are concentrating on the advancement of new technologies, such as the donepezil system. These improvements aim to boost patient adherence and intensify treatment effectiveness through novel formulations such as extended-release. The donepezil system refers to the pharmacological pathway or mechanism of action for donepezil. This medication is primarily intended for the treatment of Alzheimer's disease and varying types of dementia. For example, in October 2022, a US-based biopharmaceutical firm, Corium Innovation Inc., introduced a donepezil transdermal system (Adlarity) intended for patients suffering from mild to severe Alzheimer's disease dementia. This unique transdermal version of donepezil delivers the medicine straight through the skin, bypassing the digestive tract. This method considerably shrinks the potential of gastrointestinal side effects and offers a more user-friendly way of administration. This benefits not only patients with Alzheimer's disease but also their caregivers.
What Are the Key Segments in the Donepezil Market?
The donepezil market covered in this report is segmented -
1) By Type: 5mg, 10mg, 23mg
2) By Route Of Administration: Oral, Transdermal
3) By Application: Hospitals, Clinics, Drugstore
Subsegments:
1) By 5mg: Immediate-Release 5mg, Orally Disintegrating 5mg
2) By 10mg: Immediate-Release 10mg, Orally Disintegrating 10mg
3) By 23mg: Extended-Release 23mg, Film-Coated 23mg
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21174&type=smp
Who Are the Key Players Shaping the Donepezil Market's Competitive Landscape?
Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group
What Geographic Markets Are Powering Growth in the Donepezil Market?
North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21174
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Driving Donepezil Market Growth in 2025: The Role of Rising Alzheimer's Cases Propel Growth Of The Market here
News-ID: 4184073 • Views: …
More Releases from The Business Research Company
Cold Remedies: A Leading Driver Behind Rising Respiratory Infections Driving The …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Cold Remedies Industry Market Size Be by 2025?
The market size for cold remedies has seen considerable growth in the past years. It is projected to expand from $9.31 billion in 2024 to $9.82 billion in 2025 with a compound annual growth rate (CAGR) of 5.4%.…
Comprehensive 2025 Electrocompetent Cells Market Overview: Trends, Forecasts, an …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Electrocompetent Cells Market Through 2025?
In recent years, the market size for electrocompetent cells has seen significant growth. It is expected to increase from $1.43 billion in 2024 to $1.57 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%.…
Personalized Cancer Vaccines: Critical Driver Shaping the Increasing Cancer Inci …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personalized Cancer Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been robust growth in the personalized cancer vaccines market. The market size is forecasted to increase from $242.29 billion in 2024 to $256.65 billion in 2025, with a…
Comprehensive CD-19 Antibody Market Forecast 2025-2034: Growth Trends and Strate …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
CD-19 Antibody Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been significant growth in the CD-19 antibody market size in recent years. The market, which is projected to rise from $1.75 billion in 2024 to $1.89 billion in 2025, boasts a compound annual…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
